
Foghorn Therapeutics Inc.: shareholders and insiders
Price
$1.97
November 16, 2026Market cap $115M
What Ploutos Investor adds for Foghorn Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.
- Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Flagship Ventures Fund V, L.P.with 9 more personsShare of class27.2%
- Biotechnology Value Fund L Pwith 9 more personsShare of class14.3%
- FMRwith 1 more personShare of class11.6%
- Deerfield Mgmt, L.P.with 3 more personsShare of class8.64%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Flagship Ventures Fund V, L.P.with 9 more persons | 27.2% | 20.77M | Jan 13, 2026 | 13D/A | |
| Biotechnology Value Fund L Pwith 9 more persons | 14.3% | 8.51M | Oct 5, 20262 filings since May 15, 2026 | 13G/A | |
| FMRwith 1 more person | 11.6% | 6.79M | May 6, 20262 filings since Feb 12, 2025 | 13G/A | |
| Deerfield Mgmt, L.P.with 3 more persons | 8.64% | 5.14M | May 14, 2026 | 13G/A |
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter-21%
- Millennium Mgmt (Englander)In the quarter+81%
- Renaissance TechnologiesIn the quarter+14%
- AQR CapitalIn the quarter+103%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | – | – | 0.00% | |
| Citadel Advisors (Griffin) | 158.8K | -21% | $800.0K | 0.00% |
| Millennium Mgmt (Englander) | 53.5K | +81% | $300.0K | 0.00% |
| Renaissance Technologies | 432.3K | +14% | $1.5M | 0.00% |
| AQR Capital | 66.2K | +103% | $300.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 4.18% of its shares outstanding were held short, +14.1% since the report before.
- Shares held short
- 2.46M
- 4.18%
- Since the report before2.15M on Sep 30, 2026
- +14.1%
- 1.2
- 2.10M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 18%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 1.36M
- Nov 15, 2023: Shares held short 1.04M
- Nov 30, 2023: Shares held short 1.03M
- Dec 15, 2023: Shares held short 994.1K
- Dec 29, 2023: Shares held short 914.2K
- Jan 12, 2024: Shares held short 912.6K
- Jan 31, 2024: Shares held short 1.06M
- Feb 15, 2024: Shares held short 1.37M
- Feb 29, 2024: Shares held short 1.25M
- Mar 15, 2024: Shares held short 1.25M
- Mar 28, 2024: Shares held short 1.19M
- Apr 15, 2024: Shares held short 1.18M
- Apr 30, 2024: Shares held short 1.32M
- May 15, 2024: Shares held short 1.30M
- May 31, 2024: Shares held short 1.28M
- Jun 14, 2024: Shares held short 985.3K
- Jun 28, 2024: Shares held short 1.09M
- Jul 15, 2024: Shares held short 1.26M
- Jul 31, 2024: Shares held short 1.20M
- Aug 15, 2024: Shares held short 642.4K
- Aug 30, 2024: Shares held short 1.06M
- Sep 13, 2024: Shares held short 1.10M
- Sep 30, 2024: Shares held short 1.20M
- Oct 15, 2024: Shares held short 1.33M
- Oct 31, 2024: Shares held short 1.13M
- Nov 15, 2024: Shares held short 983.5K
- Nov 29, 2024: Shares held short 887.9K
- Dec 13, 2024: Shares held short 948.6K
- Dec 31, 2024: Shares held short 776.8K
- Jan 15, 2025: Shares held short 841.7K
- Jan 31, 2025: Shares held short 918.0K
- Feb 14, 2025: Shares held short 965.3K
- Feb 28, 2025: Shares held short 1.01M
- Mar 14, 2025: Shares held short 975.7K
- Mar 31, 2025: Shares held short 995.7K
- Apr 15, 2025: Shares held short 1.07M
- Apr 30, 2025: Shares held short 1.06M
- May 15, 2025: Shares held short 1.07M
- May 30, 2025: Shares held short 1.10M
- Jun 13, 2025: Shares held short 1.47M
- Jun 30, 2025: Shares held short 1.59M
- Jul 15, 2025: Shares held short 908.0K
- Jul 31, 2025: Shares held short 889.1K
- Aug 15, 2025: Shares held short 881.2K
- Aug 29, 2025: Shares held short 869.2K
- Sep 15, 2025: Shares held short 896.0K
- Sep 30, 2025: Shares held short 929.9K
- Oct 15, 2025: Shares held short 838.8K
- Oct 31, 2025: Shares held short 778.1K
- Nov 14, 2025: Shares held short 863.4K
- Nov 28, 2025: Shares held short 1.04M
- Dec 15, 2025: Shares held short 1.14M
- Dec 31, 2025: Shares held short 1.13M
- Jan 15, 2026: Shares held short 1.18M
- Jan 30, 2026: Shares held short 1.21M
- Feb 13, 2026: Shares held short 1.16M
- Feb 27, 2026: Shares held short 1.18M
- Mar 13, 2026: Shares held short 1.28M
- Mar 31, 2026: Shares held short 1.33M
- Apr 15, 2026: Shares held short 1.38M
- Apr 30, 2026: Shares held short 1.36M
- May 15, 2026: Shares held short 1.34M
- May 29, 2026: Shares held short 1.47M
- Jun 15, 2026: Shares held short 1.39M
- Jun 30, 2026: Shares held short 1.60M
- Jul 15, 2026: Shares held short 1.54M
- Jul 31, 2026: Shares held short 1.60M
- Aug 14, 2026: Shares held short 1.79M
- Aug 31, 2026: Shares held short 1.97M
- Sep 15, 2026: Shares held short 1.99M
- Sep 30, 2026: Shares held short 2.15M
- Oct 15, 2026: Shares held short 2.46M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading28.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 28.5% of the shares in the reported trades were short sales, against 43.2% in the 14 before.
- Last 14 sessionsOct 27, 2026 – Nov 13, 2026
- 28.5%
- The 14 beforeOct 7, 2026 – Oct 26, 2026
- 43.2%
- Change
- -14.7 pts
- Short sales a dayon average, of 382.8K shares
- 109.0K
- More than atof 3,649 US-listed companies, same days
- 4%
- Median of alleight in ten from 34.6% to 63.4%
- 50.1%
- Short sales
- Oct 7, 2026: Short sales 40%
- Oct 8, 2026: Short sales 46.7%
- Oct 9, 2026: Short sales 49.4%
- Oct 12, 2026: Short sales 37.4%
- Oct 13, 2026: Short sales 47.3%
- Oct 14, 2026: Short sales 44.7%
- Oct 15, 2026: Short sales 47.1%
- Oct 16, 2026: Short sales 50.9%
- Oct 19, 2026: Short sales 40.1%
- Oct 20, 2026: Short sales 46.5%
- Oct 21, 2026: Short sales 37.3%
- Oct 22, 2026: Short sales 27.8%
- Oct 23, 2026: Short sales 36.6%
- Oct 26, 2026: Short sales 30.8%
- Oct 27, 2026: Short sales 25%
- Oct 28, 2026: Short sales 29%
- Oct 29, 2026: Short sales 38.5%
- Oct 30, 2026: Short sales 27.5%
- Nov 2, 2026: Short sales 36.4%
- Nov 3, 2026: Short sales 36%
- Nov 4, 2026: Short sales 20.8%
- Nov 5, 2026: Short sales 37.8%
- Nov 6, 2026: Short sales 20.3%
- Nov 9, 2026: Short sales 23.5%
- Nov 10, 2026: Short sales 48.3%
- Nov 11, 2026: Short sales 27%
- Nov 12, 2026: Short sales 23.2%
- Nov 13, 2026: Short sales 18.1%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IBBiShares Biotechnology ETFWeight in the fund0.01%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.01%
- IWMiShares Russell 2000 ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
6 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 88
- Q4 2025: Managers 93
- Q1 2026: Managers 106
- Q2 2026: Managers 103
Institutional investors by quarter
The fund managers holding FHTX, quarter by quarter, from Q4 2020 to Q2 2025, 19 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 103 managers held 44.92M shares, worth $219M. During the quarter 15 opened a position, 18 closed one, 38 added and 25 trimmed.
The largest holders, Q2 2026
- Flagship PioneeringIn the quarter
- BvfIn the quarter
- FMRIn the quarter-5.6%
- Deerfield ManagementIn the quarter
- BlackRockIn the quarter+11%
- Raymond James FinancialIn the quarter-4.3%
- Euclidean CapitalIn the quarter
- Vanguard Capital ManagementIn the quarter
- Geode Capital ManagementIn the quarter+7.4%
- SirenIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Flagship Pioneering | 12.67M | $62M | |
| Bvf | 5.84M | $29M | |
| FMR | 5.71M | -5.6% | $28M |
| Deerfield Management | 4.39M | $21M | |
| BlackRock | 2.63M | +11% | $13M |
| Raymond James Financial | 2.49M | -4.3% | $12M |
| Euclidean Capital | 1.57M | $7.7M | |
| Vanguard Capital Management | 1.49M | $7.3M | |
| Geode Capital Management | 910.9K | +7.4% | $4.4M |
| Siren | 720.7K | $3.5M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Foghorn Therapeutics's filings show?
Who buys and sells is one part of Foghorn Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold FHTX?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $1.5M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.